{
  "id": "1c7bf565-ed5a-4d6e-b541-2d7f30b36171",
  "title": "Figs executive chair Heather Hasson sells $15,954 in stock",
  "link": "https://www.investing.com/news/insider-trading-news/figs-executive-chair-heather-hasson-sells-15954-in-stock-93CH-3760212",
  "description": "",
  "author": "Investing.com",
  "published": "2024-12-07 01:07:46",
  "source": "https://www.investing.com/rss/news.rss",
  "categories": null,
  "byline": "Investing.com",
  "length": 2182,
  "excerpt": "Figs executive chair Heather Hasson sells $15,954 in stock",
  "siteName": "Investing.com",
  "favicon": "",
  "text": "Heather Hasson, Executive Chair at FIGS, Inc. (NYSE:FIGS), recently sold 3,076 shares of the company's Class A Common Stock. The shares were sold at an average price of $5.1868 each, amounting to a total transaction value of $15,954. This sale was conducted to cover taxes and fees associated with the vesting and settlement of restricted stock units (RSUs), as per a 10b5-1 plan. Following this transaction, Hasson holds 381,076 shares directly, with additional shares held indirectly through trusts and other entities.The transaction comes as FIGS maintains a strong balance sheet with a current ratio of 4.58x, indicating robust liquidity. According to InvestingPro analysis, the company's stock has experienced significant volatility, declining about 27% over the past year. While FIGS trades at a premium valuation with a P/E ratio of 81x, the company maintains impressive gross profit margins of 68%. Investors seeking detailed insights can access comprehensive analysis through InvestingPro's exclusive research reports, available for over 1,400 US stocks including FIGS. In other recent news, FIGS, a prominent player in the healthcare apparel industry, reported mixed results for Q3. Despite a 17% growth, the company experienced a net revenue decrease of 2% to $140.2 million, coupled with a net loss of $1.7 million. This is in contrast to the previous year's Q3 profit of $6.1 million. The company's scrubwear sales saw a marginal increase of 2%, however, non-scrubwear sales, particularly footwear, declined by 16%. In response to these developments, FIGS revised its 2024 revenue outlook to a decline of 1% to flat and adjusted its EBITDA margin projections to approximately 8%. The company plans to bolster its growth by expanding its international presence, with a focus on Asia. In addition, FIGS is investing in community engagement and education initiatives through a $25 million investment in a new company, OOG. While the company faces challenges, these recent developments illustrate FIGS' commitment to strategic growth and community engagement. This article was generated with the support of AI and reviewed by an editor. For more information see our T\u0026C.",
  "image": "https://i-invdn-com.investing.com/news/World_News_9_800x533_L_1420026261.jpg",
  "html": "\u003cdiv id=\"readability-page-1\" class=\"page\"\u003e\u003cdiv id=\"article\"\u003e\n\u003cp\u003eHeather Hasson, Executive Chair at FIGS, Inc. (NYSE:FIGS), recently sold 3,076 shares of the company\u0026#39;s Class A Common Stock. The shares were sold at an average price of $5.1868 each, amounting to a total transaction value of $15,954. This sale was conducted to cover taxes and fees associated with the vesting and settlement of restricted stock units (RSUs), as per a 10b5-1 plan. Following this transaction, Hasson holds 381,076 shares directly, with additional shares held indirectly through trusts and other entities.The transaction comes as FIGS maintains a strong balance sheet with a current ratio of 4.58x, indicating robust liquidity. According to \u003ca href=\"https://www.investing.com/pro/FIGS\"\u003eInvestingPro\u003c/a\u003e analysis, the company\u0026#39;s stock has experienced significant volatility, declining about 27% over the past year. While FIGS trades at a premium valuation with a P/E ratio of 81x, the company maintains impressive gross profit margins of 68%. Investors seeking detailed insights can access comprehensive analysis through InvestingPro\u0026#39;s exclusive research reports, available for over 1,400 US stocks including FIGS.\u003c/p\u003e\n\n\u003cp\u003eIn other recent news, FIGS, a prominent player in the healthcare apparel industry, reported mixed results for Q3. Despite a 17% growth, the company experienced a net revenue decrease of 2% to $140.2 million, coupled with a net loss of $1.7 million. This is in contrast to the previous year\u0026#39;s Q3 profit of $6.1 million. The company\u0026#39;s scrubwear sales saw a marginal increase of 2%, however, non-scrubwear sales, particularly footwear, declined by 16%. \u003c/p\u003e\n\u003cp\u003eIn response to these developments, FIGS revised its 2024 revenue outlook to a decline of 1% to flat and adjusted its EBITDA margin projections to approximately 8%. The company plans to bolster its growth by expanding its international presence, with a focus on Asia. \u003c/p\u003e\n\u003cp\u003eIn addition, FIGS is investing in community engagement and education initiatives through a $25 million investment in a new company, OOG. While the company faces challenges, these recent developments illustrate FIGS\u0026#39; commitment to strategic growth and community engagement.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eThis article was generated with the support of AI and reviewed by an editor. For more information see our T\u0026amp;C.\u003c/em\u003e\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e",
  "readingTime": "3 min read",
  "publishedTime": "2024-12-07T01:07:46Z",
  "modifiedTime": null
}
